Search Results 711-720 of 17678 for corticosteroid
long acting bronchodilator (LAMA, LABA) with or without an inhaled corticosteroid for at least 8 weeks prior to randomization 9. Patient has a cigarette ...
ACQ-6 ≥1.5 at Screening Visit 2. 9. Documented history of at least two asthma exacerbations requiring treatment with systemic corticosteroids (intramuscular, ...
NOTE: Patients previously treated or untreated for this condition who are asymptomatic in the absence of corticosteroid and anti-epileptic therapy are allowed.
Any change in corticosteroid-containing eye drops, systemic corticosteroids/immunosuppressives, topical ocular antibiotics, cyclosporine ophthalmic emulsion ...
Active autoimmune disease requiring systemic treatment (i.e., disease modifying agents, corticosteroids, or immunosuppressive drugs) within the past 2 years.
If patients who enter the study are receiving oral corticosteroids, they ... If a patient enters the trial receiving oral corticosteroid(s) with or ...
... corticosteroids, immunosuppressants and/or biologic therapies, in the ... Oral corticosteroid dose > 30 mg/day (prednisone or equivalent) or has not ...
... corticosteroid at the time of registration. Eastern Cooperative Oncology Group (ECOG) performance status 0-2; Patients with active hepatitis B defined by ...
Medications · Calcitonin (Miacalcin). This hormone from salmon controls calcium levels in the blood. · Calcimimetics. This type of medicine can help control ...
Patients with possible secondary femoral osteonecrosis if over the age of 11 due to trauma or corticosteroid therapy are also eligible. Exclusion Criteria ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.